BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19857300)

  • 1. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
    Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
    Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
    Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
    Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL
    Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
    Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
    J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DES exposure: an update.
    Mittendorf R; Herbst AL
    Contemp Pediatr; 1994 Nov; 11(11):59-62, 64, 66 passim. PubMed ID: 10150281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem].
    Treffers PE; Hanselaar AG; Helmerhorst TJ; Koster ME; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):675-80. PubMed ID: 11530703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological studies of the effects of diethylstilboestrol.
    Vessey MP
    IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
    Melnick S; Cole P; Anderson D; Herbst A
    N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
    Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
    Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
    Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
    Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Huo D; Anderson D; Palmer JR; Herbst AL
    Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diethylstilbestrol exposure and human genital tract abnormalities.
    Herbst AL; Scully RE; Robboy SJ
    Natl Cancer Inst Monogr; 1979 May; (51):25-35. PubMed ID: 481577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.